当前位置:首页 / 黛力新联合复方阿嗪米特治疗功能性消化不良63例分析
论著 | 更新时间:2015-12-30
|
黛力新联合复方阿嗪米特治疗功能性消化不良63例分析
Deanxit plus compound azintamide in the treatment of functional dyspepsia,a report of 63 cases

内科 201206期 页码:588-590

作者机构:广西钦州市第二人民医院消化内科,钦州市535000

基金信息:

  • 中文简介
  • 英文简介
  • 参考文献
目的观察黛力新联合复方阿嗪米特治疗功能性消化不良的临床疗效。方法将142例功能性消化不良患者随机分为两组:观察组 63例,接受黛力新联合复方阿嗪米特治疗;对照组79例,仅接受复方阿嗪米特治疗。结果观察组治疗总有效率为100.0%;对照组为78.5%;观察组疗效显著优于对照组(P<0.01);两组不良反应发生率差异无统计学意义(P>0.05)。结论黛力新联合复方阿嗪米特治疗功能性消化不良疗效好,无明显不良反应,值得临床推广应用。
ObjectiveTo observe the treatment efficacy with functional dyspepsia by deanxit plus compound azintamide.Methods142 patients with functional dyspepsia were randomly divided into two groups:the observation group (63 cases) received deanxit plus compound azintamide,the control group (79 cases) received only by compound azintamide.ResultsThe total cure rate was 100% in the observation group,superior to 78.5% in the control group(P<0.01).There was no statistical significant difference in the side effect rate between the two groups (P>0.05).ConclusionDeanxit plus compound azintamide has excellent treatment effect on functional dyspepsia without apparent side effect, signifying its broad clinical application.
  • ref

3059

浏览量

1051

下载量

0

CSCD

工具集